Patterns of Adherence to Oral Hypoglycemic Agents and Glucose Control among Primary Care Patients with Type 2 Diabetes

REFERENCES

• American Diabetes Association. Clinical practice recommendations. Diabetes Care. 2014;37.
   Web of Science ®Google Scholar
• Stark Casagrande S, Fradkin JE, Saydah SH, Rust KF, Cowie CC. The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988–2010. Diabetes Care. 2013;36:2271–2279.
   PubMed Web of Science ®Google Scholar
• Turner RC, Cull CA, Frighi V, Holman RR. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49): UK Prospective Diabetes Study (UKPDS) Group. JAMA. 1999;281:2005–2012.
   PubMed Web of Science ®Google Scholar
• UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–853.
   PubMed Web of Science ®Google Scholar
• Stratton IM, Adler AI, Neil HA, et al. Association of glycemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321:405–412.
   PubMed Web of Science ®Google Scholar
• Stuart BC, Simoni-Wastila L, Zhao L, Lloyd JT, Doshi JA. Increased persistency in medication use by U.S. Medicare beneficiaries with diabetes is associated with lower hospitalization rates and cost savings. Diabetes Care. 2009;32:647–649.
   PubMed Web of Science ®Google Scholar
• Rasmussen JN, Chong A, Alter DA. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA. 2007;297:177–186.
   PubMed Web of Science ®Google Scholar
• Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care. 2004;27:1218–1224.
   PubMed Web of Science ®Google Scholar
• Odegard PS, Capoccia K. Medication taking and diabetes: a systematic review of the literature. Diabetes Educ. 2007;33:1014–1029; discussion 1030–1011.
   PubMed Web of Science ®Google Scholar
• Bailey CJ, Kodack M. Patient adherence to medication requirements for therapy of type 2 diabetes. Int J Clin Pract. 2011;65:314–322.
   PubMed Web of Science ®Google Scholar
• Rubin RR. Adherence to pharmacologic therapy in patients with type 2 diabetes mellitus. Am J Med. 2005;118:27S–34S.
   PubMed Web of Science ®Google Scholar
• Mazzuca SA. Does patient education in chronic disease have therapeutic value? J Chronic Dis. 1982;35:521–529.
   PubMedGoogle Scholar
• van Eijken M, Tsang S, Wensing M, de Smet PA, Grol RP. Interventions to improve medication compliance in older patients living in the community: a systematic review of the literature. Drugs Aging. 2003;20:229–240.
   PubMed Web of Science ®Google Scholar
• Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008:CD000011.
   PubMed Web of Science ®Google Scholar
• Kalsekar ID, Madhavan SS, Amonkar MM, et al. Impact of depression on utilization patterns of oral hypoglycemic agents in patients newly diagnosed with type 2 diabetes mellitus: a retrospective cohort analysis. Clin Ther. 2006;28:306–318.
   PubMed Web of Science ®Google Scholar
• Lamberts EJ, Nijpels G, Welschen LM, et al. Long term patterns of use after initiation of oral antidiabetic drug therapy. Pharmacoepidemiol Drug Safety. 2011;20:351–358.
   PubMed Web of Science ®Google Scholar
• van Dijk L, Heerdink ER, Somai D, et al. Patient risk profiles and practice variation in nonadherence to antidepressants, antihypertensives and oral hypoglycemics. BMC Health Serv Res. 2007;7:51– 62.
   PubMed Web of Science ®Google Scholar
• Krapek K, King K, Warren SS, et al. Medication adherence and associated hemoglobin A1c in type 2 diabetes. Ann Pharmacother. 2004;38:1357–1362.
   PubMed Web of Science ®Google Scholar
• Bogner HR, Morales KH, de Vries HF, Cappola AR. Integrated management of type 2 diabetes mellitus and depression treatment to improve medication adherence: a randomized controlled trial. Ann Fam Med. 2012;10:15–22.
   PubMed Web of Science ®Google Scholar
• Sclar DA, Robison LM, Skaer TL, Dickson WM, Kozma CM, Reeder CE. Sulfonylurea pharmacotherapy regimen adherence in a Medicaid population: influence of age, gender, and race. Diabetes Educ. 1999;25:531–532, 535, 537–538.
   PubMed Web of Science ®Google Scholar
• Hansen RA, Farley JF, Droege M, Maciejewski ML. A retrospective cohort study of economic outcomes and adherence to monotherapy with metformin, pioglitazone, or a sulfonylurea among patients with type 2 diabetes mellitus in the United States from 2003 to 2005. Clin Ther. 2010;32:1308–1319.
   PubMed Web of Science ®Google Scholar
• Cohen HW, Shmukler C, Ullman R, Rivera CM, Walker EA. Measurements of medication adherence in diabetic patients with poorly controlled HbA(1c). Diabet Med. 2010;27:210–216.
   PubMed Web of Science ®Google Scholar
• Paes AH, Bakker A, Soe-Agnie CJ. Impact of dosage frequency on patient compliance. Diabetes Care. 1997;20:1512–1517.
   PubMed Web of Science ®Google Scholar
• Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2163–2196.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Adherence to Long-term Therapies: Evidence for Action. Geneva: World Health Organization; 2003.
   Google Scholar
• Moridani MY, Verjee Z, Allen LC. Analytical evaluation of hemoglobin A(1c) dual kit assay on Bio-Rad Variant II: an automated HPLC hemoglobin analyzer for the management of diabetic patients. Clin Biochem. 2003;36:317–320.
   PubMed Web of Science ®Google Scholar
• Beverly EA, Fitzgerald S, Sitnikov L, Ganda OP, Caballero AE, Weinger K. Do older adults aged 60–75 years benefit from diabetes behavioral interventions? Diabetes Care. 2013;36:1501–1506.
   PubMed Web of Science ®Google Scholar
• Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–198.
   PubMed Web of Science ®Google Scholar
• Tombaugh TN, McIntyre NJ. The mini-mental state examination: a comprehensive review. J Am Geriatr Soc. 1992;40:922–935.
   PubMed Web of Science ®Google Scholar
• Spering CC, Hobson V, Lucas JA, Menon CV, Hall JR, O’Bryant SE. Diagnostic accuracy of the MMSE in detecting probable and possible Alzheimer's disease in ethnically diverse highly educated individuals: an analysis of the NACC database. J Gerontol A Biol Sci Med Sci. 2012;67:890–896.
   PubMed Web of Science ®Google Scholar
• O’Bryant SE, Humphreys JD, Smith GE, et al. Detecting dementia with the mini-mental state examination in highly educated individuals. Arch Neurol. 2008;65:963–967.
   PubMed Web of Science ®Google Scholar
• Stewart AL, Hays RD, Ware JE. The MOS Short-form General Health Survey: Reliability and validity in a patient population. Medical Care. 1988;26:724–735.
   PubMed Web of Science ®Google Scholar
• Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16:606–613.
   PubMed Web of Science ®Google Scholar
• McCutcheon A. Latent Class Analysis. Beverly Hills, CA: Sage Publications; 1987.
   Google Scholar
• Winkler A, Teuscher AU, Mueller B, Diem P. Monotoring adherence to prescribed medication in type 2 diabetic patients treated with sulfonylureas. Swiss Med Weekly. 2002;132:379–385.
   PubMed Web of Science ®Google Scholar
• Lo Y, Mendell NR, Rubin DB. Testing the number of components in a normal mixture. Biometrika. 2001;88:767–778.
   Web of Science ®Google Scholar
• Bogner HR, de Vries HF, O’Donnell AJ, Morales KH. Measuring concurrent oral hypoglycemic and antidepressant adherence and clinical outcomes. Am J Manag Care. 2013;19:e85–92.
   PubMed Web of Science ®Google Scholar
• Muthén LK, Muthén BO. Mplus Users Guide. Version 2. Los Angeles, CA: Muthén & Muthén; 1998.
   Google Scholar
• Farmer KC. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther. 1999;21:1074–1090; discussion 1073.
   PubMed Web of Science ®Google Scholar
• Spauwen PJ, Kohler S, Verhey FR, Stehouwer CD, van Boxtel MP. Effects of type 2 diabetes on 12-year cognitive change: results from the Maastricht Aging Study. Diabetes Care. 2013;36:1554–1561.
   PubMed Web of Science ®Google Scholar
• Nguyen HT, Kirk JK, Arcury TA, et al. Cognitive function is a risk for health literacy in older adults with diabetes. Diabetes Res Clin Pract. 2013;101:141–147.
   PubMed Web of Science ®Google Scholar
• Hewitt J, Smeeth L, Chaturvedi N, Bulpitt CJ, Fletcher AE. Self management and patient understanding of diabetes in the older person. Diabet Med. 2011;28:117–122.
   PubMed Web of Science ®Google Scholar
• Sinclair AJ, Girling AJ, Bayer AJ. Cognitive dysfunction in older subjects with diabetes mellitus: impact on diabetes self-management and use of care services. All Wales Research into Elderly (AWARE) Study. Diabetes Res Clin Pract. 2000;50:203–212.
   PubMed Web of Science ®Google Scholar
• Okura T, Heisler M, Langa KM. Association between cognitive function and social support with glycemic control in adults with diabetes mellitus. J Am Geriatr Soc. 2009;57:1816–1824.
   PubMed Web of Science ®Google Scholar
• Punthakee Z, Miller ME, Launer LJ, et al. Poor cognitive function and risk of severe hypoglycemia in type 2 diabetes: post hoc epidemiologic analysis of the ACCORD trial. Diabetes Care. 2012;35:787–793.
   PubMed Web of Science ®Google Scholar
• McGuire LC, Ford ES, Ajani UA. The impact of cognitive functioning on mortality and the development of functional disability in older adults with diabetes: the second longitudinal study on aging. BMC Geriatr. 2006;6:8.
   PubMedGoogle Scholar
• OMH. African American Profile. Washington, DC: U.S. Department of Health and Human Services Office of Minority Health. http://minorityhealth.hhs.gov/omh/browse.aspx?lvl=3&lvlid=61. Accessed December 17, 2013.
   Google Scholar
• Ayalon L, Arean PA, Linkins K, Lynch M, Estes CL. Integration of mental health services into primary care overcomes ethnic disparities in access to mental health services between black and white elderly. Am J Geriatr Psychiatr. 2007;15:906–912.
   PubMed Web of Science ®Google Scholar
• Unutzer J, Katon W, Callahan CM, et al. Collaborative care management of late-life depression in the primary care setting: a randomized controlled trial. JAMA. 2002;288:2836–2845.
   PubMed Web of Science ®Google Scholar
• Bogner HR, Dahlberg B, de Vries HF, Cahill EC, Barg FK. Older patients’ views on the relationship between depression and heart disease. Family Med. 2008;40:652–657.
   PubMed Web of Science ®Google Scholar
• Renders CM, Valk GD, Griffin SJ, Wagner EH, Eijk Van JT, Assendelft WJ. Interventions to improve the management of diabetes in primary care, outpatient, and community settings: a systematic review. Diabetes Care. 2001;24:1821–1833.
   PubMed Web of Science ®Google Scholar
• Leeman J. Interventions to improve diabetes self-management: utility and relevance for practice. Diabetes Educ. 2006;32:571–583.
   PubMed Web of Science ®Google Scholar